Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Caspar Da Cunha-Bang, MD PhD, Rudy Agius, Arnon P. Kater, Mark-David Levin, MD PhD, Anders Österborg, MD PhD, Mattias Mattsson, MD, Carsten Utoft Niemann, MD PhD

Blood (2019) 134 (Supplement_1): 4304.

https://doi.org/10.1182/blood-2019-121907

Published: 2019

Journal Articles

Diagnostic 2-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study

Pia Rude Nielsen, MD, Jens Ole Eriksen, MSc, PhD, Lise M. Lindahl, MD PhD, Ulrike Wehkamp, MD, Gitte Rinds Andersen, MSc, PhD, Michael Bzorek, Kirsten Grønbæk, Professor, MD DMSc, Niels Odum, MD DMSci, Thomas Litman, Prof., Lise Mette Rahbek Gjerdrum, MD PhD

Blood (2019) 134 (Supplement_1): 2772.

https://doi.org/10.1182/blood-2019-122031

Published: 2019

Journal Articles

Thrombin Generation Assay in Plasma from Hemophilia a Patients with or without Inhibitors on Concizumab Prophylaxis: Spiking with rFVIIa or aPCC

Marianne Kjalke, PhD, Mads Kjelgaard-Hansen, Søren Andersen, Ida Hilden

Blood (2019) 134 (Supplement_1): 3639.

https://doi.org/10.1182/blood-2019-122301

Published: 2019

Journal Articles

Identification of Novel Combination Therapies Active in BCL2 Inhibitor-Resistant Patient-Derived AML Models

Courtney L Andersen, PhD, Amanda L Christie, MS, Alan Rosen, MS, Kim Maratea, DVM, PhD, Maureen Hattersley, Jon Travers, PhD, Justin Cidado, PhD, Sai Pulukuri, PhD, Jamal Saeh, PhD, Edwin Clark, PhD, Corinne Reimer, PhD, Jerome Mettetal, PhD

Blood (2019) 134 (Supplement_1): 1273.

https://doi.org/10.1182/blood-2019-129475

Published: 2019

Journal Articles

Deficiencies in Immunoglobulin Classes and Immunoglobulin G Subclasses Are Associated with Shorter Treatment Free Survival and Overall Survival in CLL

Kyle R Crassini, MBBS,BE,BSc, Eva Zhang, MBBS, Shalini Balendran, MBBS, Jane Freeman, BA,FRACP,FRCPA,MBBS,MPhil,MSc, Oliver Giles Best, PhDBSc, Cecily Forsyth, FRACP, FRCPA, MBBS, Naomi Mackinlay, Ping Han, MDPhD, William S. Stevenson, MBBS,PhD, Stephen Mulligan, PhDFRACP,FRCPA,MBBS

Blood (2017) 130 (Supplement 1): 5321.

https://doi.org/10.1182/blood.V130.Suppl_1.5321.5321

Published: 2017

Journal Articles

Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia A

Hermann Eichler, MD, Pantep Angchaisuksiri, MD, Kaan Kavakli, MD, Paul Knöbl, MD PhD, Jerzy Windyga, Victor Jimenez-Yuste, Ute Friedrich, PhD, Philip Delff Andersen, Pratima Chowdary

Blood (2017) 130 (Supplement 1): 3672.

https://doi.org/10.1182/blood.V130.Suppl_1.3672.3672

Published: 2017

Journal Articles

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Yutaka Niihara, MD, Rafael Razon, MD, Suvankar Majumdar, MD, Brian Claggett, PhD, Onyinye C. Onyekwere, MD, Alan Ikeda, MD, Tammuella Singleton, MD, Andrew Kohei Wood, MS, Rajani Singh, BS, Lan Tran, MPH, Charles William Stark, PharmD

Blood (2017) 130 (Supplement 1): 685.

https://doi.org/10.1182/blood.V130.Suppl_1.685.685

Published: 2017

Journal Articles

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Curovic Rotbain, MD, Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, Klaus Rostgaard, MSc., Michael A Andersen, MD, Carsten Utoft Niemann, MD PhD, Henrik Frederiksen, associate professor, consultant, PhD

Blood (2017) 130 (Supplement 1): 1742.

https://doi.org/10.1182/blood.V130.Suppl_1.1742.1742

Published: 2017

Journal Articles

European Post-Approval Safety Study (PASS) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including SPM, in a Large Cohort of Patients Treated with Lenalidomide, Thalidomide, and Bortezomib

Barbara Gamberi, Miguel Hernandez, Christian Berthou, Eleni Tholouli, Elena Zamagni, Roman Hájek, Monique Minnema, Meletios A Dimopoulos, Jo Caers, Niels Frost Andersen, Bjorn Andreasson, Anders Waage, MD PhD, Gerard Crotty, Elisabeth Kueenburg, Barbara Rosettani, Antonia Di Micco, Pamela Bacon, Igor Blau

Blood (2016) 128 (22): 3331.

https://doi.org/10.1182/blood.V128.22.3331.3331

Published: 2016

Journal Articles

Reinvestigation of the T-Cell Inactivation Achieved for the Prevention of TA GV HD By 2500 Gy of Gamma Irradiation, a Comparison with Pathogen Reduction

Patricia A Merkel, Hannah E Giclas, Andrew Gibula, Gillian Andersen, Vijaya Knight, Jin-Sying Lin, Grace Castro, Jennifer Green, Adonis Stassinopoulos

Blood (2016) 128 (22): 1455.

https://doi.org/10.1182/blood.V128.22.1455.1455

Published: 2016

Journal Articles

Low Representation of ETV6-RUNX1 Fusion Oncogene in Pediatric Acute Lymphoblastic Leukemia Patients from Saudi Arabia and Strong Association with Clinical Response to Day-14 of Remission Induction Therapy

Khalid Aljamaan, MD, Talal Khalid Aljumah, MBBS, Saleh Aloraibi, PhD, Muhammad Absar, MSc PhD, Giuseppe Saglio, MD, Zafar Iqbal, MPhil PhD

Blood (2015) 126 (23): 4987.

https://doi.org/10.1182/blood.V126.23.4987.4987

Published: 2015

Journal Articles

Prediagnostic Thrombocytosis Increases the Risk of Advanced Gynecological Cancer and Increases Mortality Independently of Cancer Stage – a Population-Based Study

Christen Lykkegaard Andersen, MD, Volkert Siersma, MSc, Hans Carl Hasselbalch, MD PhD, Ole Weis Bjerrum, MD, Peter Felding, MD, Bent Lind, MD, Jan Palmblad, MD PhD, Niels de Fine Olivarius, MD

Blood (2014) 124 (21): 2791.

https://doi.org/10.1182/blood.V124.21.2791.2791

Published: 2014

Journal Articles

Modulating the Antithrombin-Mediated in Vivo Clearance of Coagulation Factor VIIa

Henrik Østergaard, PhD, Lene Hansen, Hermann Pelzer, PhD, Henrik Agersø, Anette A. Pedersen, Tina H. Glue, Laust B. Johnsen, PhD, Gorm Andersen, Jais R. Bjelke, Jens Breinholt, Henning Stennicke, MSc, PhD, Prafull S. Gandhi, PhD, Ole H. Olsen, PhD, Mette B. Hermit

Blood (2014) 124 (21): 4233.

https://doi.org/10.1182/blood.V124.21.4233.4233

Published: 2014

Journal Articles

Plasma and Platelet Tissue Factor Pathway Inhibitor (TFPI) in Blood Donors and in People with Hemophilia

Paul E. R. Ellery, PhD, Cecilia Augustsson, PhD, Soren Andersen, PhD, Susan A. Maroney, DVM, PhD, Jeremy P Wood, PhD, Joan Cox Gill, MD, Ida Hilden, PhD, Alan E. Mast, MD PhD

Blood (2014) 124 (21): 4241.

https://doi.org/10.1182/blood.V124.21.4241.4241

Published: 2014

Journal Articles

Risks of Eosinophil-Related End-Organ Damage, Hematological Malignancies and Death Are Significantly Increased Even below Consensus Threshold Criteria for Blood Eosinophilia

Christen Lykkegaard Andersen, MD, Volkert Siersma, MSc, Hanne Vestergaard, MD, Peter Felding, MD, Hans Carl Hasselbalch, MD, DMSc, Niels de Fine Olivarius, MD, Ole Weis Bjerrum, MD

Blood (2013) 122 (21): 2831.

https://doi.org/10.1182/blood.V122.21.2831.2831

Published: 2013

Journal Articles

Fatigue, Distress, and Quality of Life As Covariates for Early-Stage Chronic Lymphocytic Leukemia

Eleshia Morrison, M.A., Joseph M Flynn, DO, MPH, Jeffrey A. Jones, MD, MPH, John C. Byrd, MD, Barbara L Andersen, PhD

Blood (2012) 120 (21): 2075.

https://doi.org/10.1182/blood.V120.21.2075.2075

Published: 2012

Journal Articles

Epidemiological Data On the Incidence of Co-Morbidities and Co-Medications in Patients Undergoing Total Hip or Knee Replacement Surgery: Real-World Study and Phase III Clinical Trials.

Nadia Rosencher, MD, Simon Frostick, MD, Martin Feuring, MD, Eva Kleine, Martina Brueckmann, MD, Andreas Clemens, MD, Charles Marc Samama, MD

Blood (2012) 120 (21): 2269.

https://doi.org/10.1182/blood.V120.21.2269.2269

Published: 2012

Journal Articles

LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL

Blood (2011) 118 (21): 827.

https://doi.org/10.1182/blood.V118.21.827.827

Published: 2011

Journal Articles

Safety and Preliminary Efficacy of Recombinant Activated FVII Analog (NN1731) In the Treatment of Joint Bleeds In Congenital Hemophilia Patients with Inhibitors

Erich de Paula, Kaan Kavakli, Johnny Mahlangu, Yasmin Ayob, Steven R. Lentz, Massimo Morfini, László Nemes, Silva Zupancic Salek, Midori Shima, Jerzy Windyga, Silke Ehrenforth, Henning Friis Andersen, Ampaiwan Chuansumrit, and on behalf of 1804 (ADEPT-1) Investigators

Blood (2010) 116 (21): 719.

https://doi.org/10.1182/blood.V116.21.719.719

Published: 2010

Journal Articles

Impact of Allogeneic Transplantation From Matched Related and Unrelated Donors on Clinical Outcome In Younger Adult AML Patients with FLT3 Internal Tandem Duplications

Blood (2010) 116 (21): 909.

https://doi.org/10.1182/blood.V116.21.909.909

Published: 2010

NARROW

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Diagnostic 2-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study

Thrombin Generation Assay in Plasma from Hemophilia a Patients with or without Inhibitors on Concizumab Prophylaxis: Spiking with rFVIIa or aPCC

Identification of Novel Combination Therapies Active in BCL2 Inhibitor-Resistant Patient-Derived AML Models

Deficiencies in Immunoglobulin Classes and Immunoglobulin G Subclasses Are Associated with Shorter Treatment Free Survival and Overall Survival in CLL

Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia A

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

European Post-Approval Safety Study (PASS) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including SPM, in a Large Cohort of Patients Treated with Lenalidomide, Thalidomide, and Bortezomib

Reinvestigation of the T-Cell Inactivation Achieved for the Prevention of TA GV HD By 2500 Gy of Gamma Irradiation, a Comparison with Pathogen Reduction

Low Representation of ETV6-RUNX1 Fusion Oncogene in Pediatric Acute Lymphoblastic Leukemia Patients from Saudi Arabia and Strong Association with Clinical Response to Day-14 of Remission Induction Therapy

Prediagnostic Thrombocytosis Increases the Risk of Advanced Gynecological Cancer and Increases Mortality Independently of Cancer Stage – a Population-Based Study

Modulating the Antithrombin-Mediated in Vivo Clearance of Coagulation Factor VIIa

Plasma and Platelet Tissue Factor Pathway Inhibitor (TFPI) in Blood Donors and in People with Hemophilia

Risks of Eosinophil-Related End-Organ Damage, Hematological Malignancies and Death Are Significantly Increased Even below Consensus Threshold Criteria for Blood Eosinophilia

Fatigue, Distress, and Quality of Life As Covariates for Early-Stage Chronic Lymphocytic Leukemia

Epidemiological Data On the Incidence of Co-Morbidities and Co-Medications in Patients Undergoing Total Hip or Knee Replacement Surgery: Real-World Study and Phase III Clinical Trials.

LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL

Safety and Preliminary Efficacy of Recombinant Activated FVII Analog (NN1731) In the Treatment of Joint Bleeds In Congenital Hemophilia Patients with Inhibitors

Impact of Allogeneic Transplantation From Matched Related and Unrelated Donors on Clinical Outcome In Younger Adult AML Patients with FLT3 Internal Tandem Duplications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only